{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:58:14Z","timestamp":1773287894739,"version":"3.50.1"},"reference-count":15,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T00:00:00Z","timestamp":1111449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold>Blood donation screening for West Nile virus (WNV) RNA by nucleic acid testing (NAT) was implemented in Canada in July 2003, and 14 WNV\u2003RNA\u2013positive donations were identified. Samples were screened in minipools of six donations with a WNV assay (TaqScreen, Roche). Two of the donors were identified by single\u2010donor screening that was initiated in the province of Saskatchewan, which had the highest prevalence of WNV in the country, in early September 2003.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold>The original 14 samples and follow\u2010up samples (2\u201035 days after donation), available from 13 of the 14 donors were tested with an in\u2010house, real\u2010time, quantitative WNV NAT assay that was specific for WNV. A Health Canada reference reagent was used for calibration. Immunoglobulin M (IgM) and immunoglobulin G (IgG) levels were determined with commercial enzyme\u2010linked immunosorbent assay kits.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold>All donors tested positive for the presence of WNV with the in\u2010house assay. Two donors, 18 and 19, identified by single\u2010donor testing, had extremely low levels of viremia and that could only be detected in 1:38 or 1:39 replicate tests. The titers of the remaining index samples ranged from below log2.8 (the limit of quantitation) to log4.7 NAT detectable units per mL. Three samples, from Donors\u200317, 18, and 19, were IgM\u2010positive, whereas samples from Donors\u200318 and 19 were also IgG\u2010positive. The remaining 10 donors with follow\u2010up samples all seroconverted.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold>The 14 WNV donor samples detected by routine screening were confirmed as WNV\u2003RNA\u2013positive by a WNV\u2003RNA\u2013specific in\u2010house assay and by demonstration of seroconversion in 13 of the 14 donors.<\/jats:p>","DOI":"10.1111\/j.0041-1132.2005.04384.x","type":"journal-article","created":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T16:59:56Z","timestamp":1111510796000},"page":"487-491","source":"Crossref","is-referenced-by-count":8,"title":["West Nile virus in Canadian blood donors"],"prefix":"10.1111","volume":"45","author":[{"given":"Cherie","family":"Cameron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackie","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Antonishyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Tilley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Alport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernie","family":"Eurich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale","family":"Towns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Saldanha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,3,22]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-59403-8_10"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.4.524"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00480.x"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030969"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106143442401"},{"key":"e_1_2_5_7_2","volume-title":"West Nile virus surveillance information: West Nile virus Monitor [Internet].","year":"2004"},{"key":"e_1_2_5_8_2","first-page":"65","article-title":"West Nile Virus NAT testing","volume":"118","author":"Saldanha J","year":"2004","journal-title":"Dev Biol (Basel)"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1128\/JCM.38.11.4066-4071.2000","article-title":"Rapid detection of West Nile virus from human clinical specimens, field\u2010collected mosquitoes and avian samples by a TaqMan reverse transcriptase\u2010PCR assay","volume":"38","author":"Lanciotti RS","year":"2000","journal-title":"J Clin Microbiol"},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1128\/JCM.36.12.3590-3594.1998","article-title":"Armored RNA technology for production of ribonuclease\u2010resistant viral RNA controls and standards","volume":"36","author":"Pasloske BL","year":"1998","journal-title":"J Clin Microbiol"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.04151.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-4475-7"},{"key":"e_1_2_5_13_2","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198522317.001.0001","volume-title":"The GLIM system: release 4 manual","author":"Francis B","year":"1993"},{"key":"e_1_2_5_14_2","first-page":"281","article-title":"Update: West Nile virus screening of blood donations and transfusion\u2010associated transmission\u2014United States, 2003","volume":"53","author":"Centers for Disease Control and Prevention (CDC).","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_5_15_2","first-page":"57a","article-title":"Yield of West Nile virus screening of US blood donors [11\u2010abstract book part 1]","volume":"102","author":"Caglioti S","year":"2003","journal-title":"Blood"},{"key":"e_1_2_5_16_2","volume-title":"West Nile virus: statistics, surveillance and control [Internet].","year":"2004"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0041-1132.2005.04384.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0041-1132.2005.04384.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T04:36:57Z","timestamp":1706071017000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0041-1132.2005.04384.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,22]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1111\/j.0041-1132.2005.04384.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0041-1132.2005.04384.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,22]]}}}